A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Completed · Phase 3

Conditions studied: Breast Neoplasms

In brief

To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus paclitaxel to determine which treatment works better against breast cancer

Key facts

Study ID

NCT00373256

Run by

Pfizer

People needed

488

Starts

2006-11-01

Expected to finish

2011-08-01

Last updated by the study team

2012-09-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of advanced breast cancer.
• Measurable disease as per RECIST (Response Evaluation Criterion) in Solid Tumors or bone-only disease.
• ECOG (Eastern Cooperative Oncology Group) performance status 0 or 1.

You may not qualify if…

• No prior treatment with cytotoxics in the advanced disease setting.
• HER2/neu positive disease unless trastuzumab was previously received or is contraindicated.
• Treatment with a taxane in the adjuvant setting unless disease free interval >12 months after end of treatment.

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Daphne, Alabama, United States
• Pfizer Investigational Site — Mobile, Alabama, United States
• Pfizer Investigational Site — Mobile, Alabama, United States
• Pfizer Investigational Site — Flagstaff, Arizona, United States
• Pfizer Investigational Site — Sedona, Arizona, United States
• Pfizer Investigational Site — Hot Springs, Arkansas, United States
• Pfizer Investigational Site — Anaheim, California, United States
• Pfizer Investigational Site — Antioch, California, United States
• Pfizer Investigational Site — Antioch, California, United States
• Pfizer Investigational Site — Baldwin Park, California, United States
• Pfizer Investigational Site — Bellflower, California, United States
• Pfizer Investigational Site — Fontana, California, United States
• Pfizer Investigational Site — Fountain Valley, California, United States
• Pfizer Investigational Site — Gilroy, California, United States
• Pfizer Investigational Site — Hawthorne, California, United States
• Pfizer Investigational Site — Hayward, California, United States
• Pfizer Investigational Site — Irvine, California, United States
• Pfizer Investigational Site — La Jolla, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Bessemer, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.